ConductScience.org, home

Paper30733337

Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.

Folk WP and 7 others. J Biol Chem, 2019. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin. Papers, record 30733337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30733337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
PubMed
Journal
J Biol Chem
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2024-07-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Folk WPWatson P
2Kumari AAlpana
3Iwasaki TTetsushi
4Pyndiah SSlovénie
5Johnson JCJoanna C
6Cassimere EKErica K
7Abdulovic-Cui ALAmy L
8Sakamuro DDaitoku

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adaptor Proteins, Signal TransducingMajor topic
Ataxia Telangiectasia Mutated ProteinsMajor topic
CisplatinMajor topic
Drug Resistance, NeoplasmMajor topic
E2F1 Transcription FactorMajor topic
NeoplasmsMajor topic
Nuclear ProteinsMajor topic
Transcription, GeneticMajor topic
Tumor Suppressor ProteinsMajor topic
Acid Anhydride Hydrolases
Cell Cycle Proteins
Cell Line, Tumor
DNA Breaks, Double-Stranded
DNA Repair
DNA Repair Enzymes
DNA, Neoplasm
DNA-Binding Proteins
Histones
Humans
MRE11 Homologue Protein
Signal Transduction

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA140379NCI NIH HHSUnited StatesR01CA140379PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122573178RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells.Nucleic Acids Res2012https://conductscience.org/library/papers/22573178PubMed
212792653Yeast histone 2A serine 129 is essential for the efficient repair of checkpoint-blind DNA damage.EMBO Rep2003https://conductscience.org/library/papers/12792653PubMed
325512053ATM and ATR as therapeutic targets in cancer.Pharmacol Ther2015https://conductscience.org/library/papers/25512053PubMed
49733515Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.Science1998https://conductscience.org/library/papers/9733515PubMed
5366407The role of cis-platinum in solid-tumor therapy.N Engl J Med1979https://conductscience.org/library/papers/366407PubMed
628382507Cisplatin nephrotoxicity: a review of the literature.J Nephrol2018https://conductscience.org/library/papers/28382507PubMed
716531125gammaH2AX and MDC1: anchoring the DNA-damage-response machinery to broken chromosomes.DNA Repair (Amst)2006https://conductscience.org/library/papers/16531125PubMed
812717439Chk2 activates E2F-1 in response to DNA damage.Nat Cell Biol2003https://conductscience.org/library/papers/12717439PubMed
921447800c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.Sci Signal2011https://conductscience.org/library/papers/21447800PubMed
1018483401Activation of the cellular DNA damage response in the absence of DNA lesions.Science2008https://conductscience.org/library/papers/18483401PubMed
1122469522The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art.Biochem Pharmacol2012https://conductscience.org/library/papers/22469522PubMed
1224002223Push back to respond better: regulatory inhibition of the DNA double-strand break response.Nat Rev Mol Cell Biol2013https://conductscience.org/library/papers/24002223PubMed
138782822BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.Nat Genet1996https://conductscience.org/library/papers/8782822PubMed
1411459832Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.Genes Dev2001https://conductscience.org/library/papers/11459832PubMed
1519808981Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.Mol Cancer Ther2009https://conductscience.org/library/papers/19808981PubMed
1617671430Bin1 interacts with and restrains the DNA end-binding protein complex Ku.Cell Cycle2007https://conductscience.org/library/papers/17671430PubMed
1719005492GammaH2AX and cancer.Nat Rev Cancer2008https://conductscience.org/library/papers/19005492PubMed
189395479Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.J Biol Chem1997https://conductscience.org/library/papers/9395479PubMed
1912527885ATM is a target for positive regulation by E2F-1.Oncogene2003https://conductscience.org/library/papers/12527885PubMed
2020177397Genomic instability--an evolving hallmark of cancer.Nat Rev Mol Cell Biol2010https://conductscience.org/library/papers/20177397PubMed

See all 60 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41250205tRNA-derived fragment tRF-24 drives CELF1 phase separation to promote oncogenic splicing in esophageal squamous cell carcinoma.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41250205PubMed
40808414Bridging autophagy and endolysosomal dysfunction: Role of bridging integrator 1 in Alzheimer's disease.Neural Regen Res2026https://conductscience.org/library/papers/40808414PubMed
40346580Tumor cell-intrinsic BIN1 deficiency promotes the immunosuppression and impedes ferroptosis of non-small cell lung cancer via G3BP1-mediated degradation of STAT1.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40346580PubMed
40034505Lower expression of BIN1's neuronal isoform in vulnerable excitatory neurons increases risk in Alzheimer's disease.J Alzheimers Dis Rep2025https://conductscience.org/library/papers/40034505PubMed
38934020Dementia and metabolic syndrome: a bibliometric analysis.Front Aging Neurosci2024https://conductscience.org/library/papers/38934020PubMed
37781737Glycolytic enzyme PFKFB3 regulates sphingosine 1-phosphate receptor 1 in proangiogenic glomerular endothelial cells under diabetic condition.Am J Physiol Cell Physiol2023https://conductscience.org/library/papers/37781737PubMed
37239845GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process.Int J Mol Sci2023https://conductscience.org/library/papers/37239845PubMed
36890396BIN1 in cancer: biomarker and therapeutic target.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/36890396PubMed
35984905Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias.Blood2022https://conductscience.org/library/papers/35984905PubMed
35526014BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.Mol Neurodegener2022https://conductscience.org/library/papers/35526014PubMed
35463320Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment.Front Oncol2022https://conductscience.org/library/papers/35463320PubMed
35303867Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.World J Surg Oncol2022https://conductscience.org/library/papers/35303867PubMed
34948122New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.Int J Mol Sci2021https://conductscience.org/library/papers/34948122PubMed
34733369Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 increases cellular proliferation and colony formation capacity in lung cancer via activation of E2F transcription factor 1.Oncol Lett2021https://conductscience.org/library/papers/34733369PubMed
32601397Cellular senescence and Alzheimer disease: the egg and the chicken scenario.Nat Rev Neurosci2020https://conductscience.org/library/papers/32601397PubMed
32203529A long noncoding RNA sensitizes genotoxic treatment by attenuating ATM activation and homologous recombination repair in cancers.PLoS Biol2020https://conductscience.org/library/papers/32203529PubMed
31981470"Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.Aging Cell2020https://conductscience.org/library/papers/31981470PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30733337

GET https://conductscience.org/api/papers/v1/30733337/references?page=2